News

The Manila Times10m
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
Within R&D, Novo Nordisk completed the REDEFINE 2 trial, where CagriSema demonstrated superior weight loss of 15.7% in adults ...
The Independent on MSN46m
Forget Ozempic face – should we be worried about Ozempic teeth?
Forget Ozempic face – should we be worried about Ozempic teeth? - LET’S UNPACK THAT: With more and more people signing up for ...